current
qualiti
control
qc
pattern
chines
materia
medica
cmm
lack
suitabl
method
indic
evalu
safeti
efficaci
effect
imped
smooth
develop
cmm
review
main
problem
current
qc
pattern
cmm
princip
focus
content
determin
constitu
summar
inspir
qc
biolog
product
introduc
aim
introduc
suitabl
tool
qc
cmm
biopot
assay
feasibl
qc
pattern
cmm
analyz
confirm
relev
research
year
practic
applic
biopot
assay
qc
cmm
last
year
propos
biopot
assay
integr
part
qc
pattern
cmm
assay
make
qc
indic
relat
clinic
safeti
efficaci
supplement
exist
qc
system
cmm
chines
materia
medica
cmm
import
part
global
medicinc
market
use
prevent
treat
diseas
larg
portion
popul
year
peppin
et
al
zhang
et
al
last
decad
cmm
becom
popular
around
world
huge
medicin
econom
valu
howev
due
difficulti
establish
feasibl
qualiti
control
qc
pattern
cmm
use
evalu
safeti
efficaci
effect
develop
cmm
approach
bottleneck
articl
major
topic
current
qc
pattern
cmm
discuss
put
forward
qc
pattern
method
cmm
center
biopot
assay
mani
year
experi
field
order
suppli
improv
exist
qc
system
cmm
hope
pattern
provid
new
research
idea
establish
qc
system
develop
world
tradit
medicin
especi
herbal
medicin
present
medicin
world
classifi
three
kind
follow
cmm
chemic
synthet
drug
csd
biolog
product
bp
among
csd
mainstream
clinic
use
quick
efficaci
directli
act
target
organ
cmm
system
ancient
medic
practic
quit
differ
substanc
methodolog
philosophi
modern
medicin
own
distinguish
featur
play
crucial
role
health
mainten
billion
peopl
worldwid
cheung
hosbach
et
al
howev
also
due
special
featur
systemat
holism
multitarget
multichannel
result
complex
chemic
constitu
often
hard
control
qualiti
cmm
effect
way
process
global
modern
cmm
key
point
keep
control
consist
qualiti
cmm
meanwhil
also
indispens
serv
clinic
guidanc
qc
standard
current
qc
cmm
pattern
qc
method
csd
mainli
focus
content
determin
singl
constitu
limit
number
constitu
actual
meet
need
poor
correl
efficaci
specif
repres
reason
given
follow
effect
substanc
cmm
clear
establish
qc
standard
cmm
one
sever
constitu
chosen
indic
analyz
qualit
quantit
detect
exist
constitu
determin
content
howev
littl
direct
intern
relev
constitu
clinic
efficaci
well
safeti
exampl
chines
pharmacopoeia
pharmacopoeia
committe
p
r
china
qc
indic
cordycep
famou
preciou
cmm
expens
gold
determin
content
adenosin
adenosin
activ
constitu
cordycep
poorli
relat
clinic
efficaci
indic
cmm
may
activ
one
nonexclus
often
wide
exist
variou
kind
herbal
medicin
instanc
ginsenosid
indic
ginseng
radix
et
rhizoma
pharmacopoeia
committe
p
r
china
also
exist
notoginseng
radix
et
rhizoma
american
ginseng
even
differ
part
medicin
plant
indic
still
wide
distribut
anoth
exampl
ginseng
ginseng
fibrou
root
ginseng
leav
contain
ginsenosid
confusingli
part
ginseng
use
medicin
histori
main
root
total
ginsenosid
gener
current
market
price
dollar
per
kilogram
ginseng
fibrou
root
contain
total
ginsenosid
price
dollar
per
kilogram
ginseng
leav
contain
total
ginsenosid
price
dollar
per
kilogram
market
yu
et
al
evalu
qualiti
ginseng
radix
et
rhizoma
accord
content
total
ginsenosid
ginseng
fibrou
root
ginseng
leav
obvious
costeffect
ginseng
contrari
clinic
experi
actual
applic
thousand
year
sinc
complex
variou
kind
constitu
cmm
especi
compound
prepar
difficult
determin
authent
evalu
qualiti
cmm
detect
exist
content
one
sever
constitu
take
famou
chines
patent
drug
liuwei
dihuang
pill
exampl
made
six
chines
herbal
medicin
prosec
rehmannia
radix
corni
fructu
moutan
cortex
dioscorea
rhizoma
alismati
rhizoma
poria
contain
thousand
compon
current
qc
standard
drug
determin
content
loganin
paeonol
pharmacopoeia
committe
p
r
china
judg
number
constitu
repres
sever
constitu
could
less
total
amount
substanc
repres
could
less
obvious
qc
mode
base
qualit
quantit
determin
singl
constitu
hardli
evalu
qualiti
cmm
object
comprehens
therefor
necessari
establish
feasibl
effect
qc
pattern
combin
clinic
demand
especi
driven
translat
medicin
new
develop
tendenc
bioscienc
world
miln
kaitin
sarkar
develop
qc
pattern
cmm
guarante
stabil
consist
drug
also
associ
clinic
efficaci
safeti
order
serv
clinic
observ
substanc
csd
bp
cmm
effect
manufactur
techniqu
made
find
cmm
similar
bp
substanc
cmm
similar
bp
compar
csd
csd
often
consist
singl
constitu
differ
cmm
bp
cmm
compos
one
multipl
class
compound
bp
usual
made
polypeptid
protein
molecular
weight
within
limit
accord
effect
manufactur
techniqu
made
substanc
three
kind
drug
cmm
also
similar
bp
csd
product
method
condit
may
variou
substanc
almost
invari
exampl
although
product
techniqu
vitamin
c
vc
includ
reichstein
procedur
reichstein
onestep
synthesi
method
anderson
et
al
twostep
synthesi
method
hancock
viola
final
constitu
structur
vc
hardli
chang
bp
substanc
close
relat
manufactur
process
product
techniqu
condit
chang
substanc
bp
also
chang
well
properti
efficaci
like
bp
qualiti
substanc
cmm
also
influenc
product
condit
varieti
produc
area
harvest
time
process
technolog
nevertheless
current
qc
pattern
cmm
mainli
pattern
csd
bp
csd
content
constitu
directli
relat
efficaci
safeti
bp
biopot
assay
major
qc
method
content
detect
gener
use
puriti
examin
cmm
morpholog
identif
content
detect
constitu
use
control
qualiti
without
provis
biopot
assay
therefor
qc
pattern
cmm
rais
question
use
qc
pattern
bp
refer
two
kind
drug
similar
fact
biopot
assay
practic
valuabl
conduc
cmm
degre
compar
content
determin
chemic
constitu
develop
registr
control
biolog
biotechnologyderiv
product
biopot
assay
play
key
role
alreadi
matur
appli
establish
qc
standard
bp
biopot
assay
reflect
bioactiv
drug
consist
clinic
efficaci
larg
extent
physic
chemic
analysi
method
repres
one
aspect
physicochem
properti
drug
may
correspond
efficaci
figur
introduct
biopot
assay
qc
pattern
system
cmm
assist
chemic
analysi
identifi
authent
cmm
also
evalu
qualiti
efficaci
research
biopot
assay
associ
safeti
efficaci
superior
qc
drug
unknown
complex
constitu
detect
chemic
analysi
method
biopot
assay
quantit
bioident
test
play
key
role
develop
registr
control
biolog
biotechnologyderiv
product
xiao
et
al
detect
intens
drug
effect
live
organ
respons
intens
drug
control
act
live
organ
organ
tissu
compar
calcul
dose
standard
drug
biopot
assay
includ
test
vivo
vitro
biopot
assay
vivo
base
anim
reflect
mode
drug
action
human
bodi
classic
method
chines
pharmacopoeia
pharmacopoeia
committe
p
r
china
unit
state
pharmacopoeia
unit
state
pharmacopei
convent
potenc
recombin
human
glucagon
somatropin
must
determin
manufactur
process
biopot
assay
vitro
use
evalu
bioactiv
drug
organ
tissu
microorgan
enzym
cell
seri
detect
method
et
al
pauli
et
al
coomb
et
al
two
assay
characterist
biospecif
effect
live
organ
drug
better
demonstr
vivo
repeat
reliabl
precis
biopot
assay
vitro
superior
vivo
therefor
select
assay
determin
accord
differ
purpos
subject
major
select
principl
biolog
assay
correl
clinic
efficaci
modern
pharmacolog
effect
drug
test
result
repeat
index
sensit
reflect
dose
chang
drug
point
note
repeat
sensit
biopot
assay
evalu
angl
biostatist
requir
physicochem
test
last
least
feasibl
biopot
assay
effici
one
easi
gener
besid
cellbas
assay
enzymat
reaction
assay
routin
potenc
detect
method
microcalorimetri
base
biothermodynam
also
develop
determin
drug
potenc
year
present
energi
transduct
interact
drug
organ
realtim
onlin
effici
way
use
quantit
bioident
test
figur
present
biopot
assay
mainli
appli
qc
field
biochem
drug
bp
suitabl
drug
unclear
activ
constitu
complex
vari
structur
content
bioactiv
detect
physicochem
analysi
janzen
popaburk
mireslui
sun
et
al
thangam
sudha
et
al
cmm
qualiti
reflect
chemic
constitu
also
efficaci
safeti
relat
materi
sinc
biopot
assay
avail
differ
assay
format
depend
action
mode
drug
reliabl
predict
safeti
efficaci
extent
destefano
morri
qc
pattern
cmm
may
gain
ground
biopot
assay
part
alreadi
research
report
biopot
assay
use
cmm
chines
pharmacopoeia
qualiti
toxic
leech
digitali
control
use
biopot
assay
pharmacopoeia
committe
p
r
china
research
qc
cmm
product
garlic
oil
zhang
leonuri
herba
yang
wang
sparganii
rhizoma
chen
et
al
coici
semen
li
et
al
huangqin
decoct
tilton
et
al
gegen
qinlian
decoct
applic
biopot
assay
also
report
token
possibl
feasibl
establish
novel
qc
pattern
cmm
guarante
stabil
control
standard
also
directli
relat
safeti
efficaci
medicin
word
establish
qc
pattern
cmm
base
chemic
analysi
biopot
assay
benefici
develop
modern
cmm
figur
research
group
first
propos
establish
qc
pattern
cmm
appropri
biolog
assay
order
evalu
qualiti
efficaci
cmm
object
flexibl
meanwhil
devot
establish
mode
sinc
appli
cmm
unclear
activ
constitu
cmm
toxic
constitu
valuabl
cmm
cmm
inject
obtain
satisfactori
result
number
cmm
favor
cur
effect
contain
unclear
activ
constitu
among
qualiti
hard
control
routin
physic
chemic
analysi
essenti
carri
suitabl
research
biopot
assay
take
isatidi
radix
exampl
one
qc
indic
detect
exist
arginin
pharmacopoeia
committe
p
r
china
neither
main
activ
constitu
specif
one
exist
isatidi
radix
therefor
detect
arginin
almost
meaningless
qc
isatidi
radix
accord
major
efficaci
modern
pharmacolog
action
antivir
activ
bacteriostat
activ
isatidi
radix
lin
et
al
use
biopot
assay
detect
antivir
bacteriostat
activ
li
et
al
tang
et
al
wei
et
al
final
optim
biopot
assay
isatidi
radix
base
detect
hemagglutin
activ
research
establish
two
antivir
activ
hemagglutin
activ
influenza
viru
neuraminidas
activ
detect
method
isatidi
radix
contrast
analysi
found
method
good
repeat
could
use
evalu
bioactiv
differ
isatidi
radix
relationship
agglutin
activ
antivir
effect
isatidi
radix
verifi
agglutin
detect
method
superior
safeti
inexpens
easi
practic
novel
method
could
reflect
pharmacodynam
effect
antiinfluenza
toxicolog
case
pyrrolizidin
alkaloid
aristoloch
acid
xiao
liu
global
concern
qualiti
safeti
cmm
skyrocket
worldwid
research
begun
focu
qc
cmm
mani
chines
herbal
medicin
highli
toxic
narrow
margin
safeti
therapeut
toxic
dose
gutser
et
al
toxic
often
attribut
toxic
constitu
exampl
hypertox
herb
aconitum
l
deem
exist
diester
diterpenoid
alkaloid
dda
aconitin
mesaconitin
hypaconitin
ameri
chan
singhub
et
al
current
qc
method
herb
aconitum
l
quantit
analysi
three
toxic
dda
liquid
chromatographi
chen
et
al
pharmacopoeia
committe
p
r
china
csupor
et
al
jiang
et
al
lu
et
al
xie
et
al
meet
need
clinic
practic
mani
constitu
toxic
one
besid
three
dda
herb
aconitum
l
bisset
dong
et
al
moreov
toxic
three
dda
differ
aconitin
mesaconitin
hypaconitin
sampl
total
dda
content
often
differ
total
toxic
bisset
dong
et
al
thu
limit
total
content
three
dda
enough
ensur
safeti
herb
aconitum
l
clinic
order
investig
toxic
herb
aconitum
l
research
group
establish
biopot
assay
compar
total
toxic
three
dda
qin
et
al
studi
minimum
lethal
dose
mld
test
sampl
standard
determin
respect
toxic
potenc
calcul
compar
mld
three
major
dda
herb
aconitum
l
analyz
use
lc
method
current
method
evalu
toxic
herb
aconitum
l
found
total
toxic
extract
herb
aconitum
l
greater
three
alkaloid
word
content
three
dda
fail
repres
total
toxic
herb
aconitum
l
biopot
assay
could
character
total
toxic
determin
toxic
potenc
tabl
studi
may
reveal
biopot
assay
power
method
safeti
assess
qc
cmm
toxic
mani
valuabl
rare
speci
appli
cmm
sinc
thousand
year
ago
alv
et
al
leal
et
al
mishra
et
al
clinic
effect
got
valid
histori
also
promot
develop
cmm
nevertheless
often
hard
evalu
qualiti
cmm
convent
method
chromatograph
spectrum
analysi
exampl
exist
qc
cordycep
detect
content
adenosin
pharmacopoeia
committe
p
r
china
neither
mainli
activ
constitu
exclus
constitu
moreov
valuabl
medicin
anim
horn
market
often
sold
form
powder
hard
identifi
routin
morpholog
identif
yan
et
al
accordingli
method
determin
bioactiv
valuabl
rare
cmm
would
valuabl
chen
et
al
kim
et
al
tang
et
al
yan
et
al
reason
group
investig
metabol
action
natur
cordycep
cultur
mycelia
growth
escherichia
coli
method
biopot
assay
zhou
et
al
result
show
cordycep
dispar
produc
area
speci
made
differ
influenc
growth
metabol
e
coli
differ
could
use
distinguish
cordycep
differ
grade
evalu
qualiti
addit
yan
et
al
studi
bioactiv
cervi
cornu
pantotrichum
cervi
cornu
saiga
tatarica
cornu
e
coli
growth
use
biopot
assay
find
heat
chang
regular
microbi
growth
found
method
could
qualit
quantit
reflect
bioactiv
medicin
method
base
biopot
assay
could
provid
paradigm
qc
valuabl
rare
cmm
cmm
inject
wide
use
china
ji
et
al
xue
roy
owe
power
rapid
therapeut
effect
order
control
qualiti
cmm
inject
modern
advanc
method
hplc
yan
et
al
gc
qi
et
al
ms
zeng
et
al
capillari
electrophoresi
ganzera
hyphen
techniqu
fan
et
al
appli
identifi
compound
howev
mani
constitu
detect
lack
absorpt
spectra
especi
biopollut
pharmaceut
adjuv
biolog
activ
constitu
result
advers
drug
reaction
advers
drug
event
zeng
jiang
henc
necessari
establish
novel
approach
comprehens
qc
cmm
inject
biolog
viewpoint
boyl
et
al
jiang
et
al
liu
et
al
ren
et
al
group
combin
biopot
assay
chemic
analysi
detect
fluctuat
qualiti
yinzhihuang
inject
chemic
biolog
aspect
figur
hplc
thermal
activ
monitor
appli
develop
chemic
fingerprint
biolog
fingerprint
normal
sampl
bought
regular
factori
artifici
abnorm
sampl
expos
differ
condit
includ
temperatur
light
air
steril
respect
found
abnorm
sampl
could
correctli
distinguish
two
analysi
techniqu
combin
method
could
use
earli
predict
current
pharmacolog
activ
chemic
constitu
cmm
well
explor
therefor
content
determin
known
activ
constitu
cmm
still
import
way
qc
cmm
introduc
biopot
assay
qc
cmm
mean
replac
chemic
analyz
method
complet
biopot
assay
advantag
relat
effect
focu
one
two
pharmacolog
activ
also
enough
thought
total
relat
clinic
efficaci
meanwhil
aspect
precis
reproduc
biopot
assay
may
good
chemic
analysi
fact
chemic
analysi
like
use
determin
authent
cmm
biopot
assay
suitabl
appli
evalu
therefor
neither
exclud
qc
pattern
cmm
introduct
biopot
assay
qc
cmm
reveal
combin
multipl
disciplin
technolog
method
take
advantag
biolog
detect
chemic
analysi
promot
develop
qc
pattern
cmm
benefici
attempt
modern
normal
standard
cmm
even
though
would
quit
technic
problem
definit
highqual
cmm
select
biolog
detect
method
ration
vitro
activ
evalu
believ
integr
applic
biopot
assay
solv
continu
research
unremit
effort
scientif
technolog
worker
qc
pattern
cmm
base
chemic
analysi
biopot
assay
also
provid
benefici
research
idea
method
qc
cmm
develop
botan
drug
world
